With reference to the €150 million capital increase announced today by Sequana, EXOR expresses its commitment to partially exercise the rights to which it is entitled so that the French government-controlled Strategic Investment Fund can become a shareholder.
After the capital raise – consistently with the strategy to simplify and reduce non-core investments – EXOR’s stake in Sequana will be diluted on the basis of the features of the capital increase that will be finalized over the next few days.
At the same time, EXOR has ended the shareholders’ agreement signed with DLMD in July 2010.
Files
